Skip to main content
Premium Trial:

Request an Annual Quote

Schott Licenses Microarray Slide Surface Chemistry from Accelr8

NEW YORK, Dec. 6 (GenomeWeb News) - Schott Nexterion has taken an exclusive license to surface chemistry for microarrays from Accelr8 Technology, Accelr8 said today.


The deal follows an earlier agreement under which Schott sold Accelr8 microarray slides under its name. Schott, based in Jena, Germany, now obtained a two-year exclusive manufacturing and marketing license to Accelr8's OptiChem-coated microarrays for protein applications, which can be extended for one year.


The company also took a non-exclusive license for other microarray applications. Accelr8 will be Schott's only supplier of permeable hydrogel coatings for microarray slides during that time.


Accelr8 will continue to manufacture OptiChem slides for Schott until Schott's own production facility goes online next April.


In addition, Schott has obtained an option for a technology transfer license for multiplexed microarray plates in multi-well microtiter plate format from Accelr8.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.